Cytek Biosciences
CTKB
CTKB
104 hedge funds and large institutions have $728M invested in Cytek Biosciences in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 29 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 19
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $152K
Holders
104
Holding in Top 10
–
Calls
–
Puts
$152K
Top Buyers
| 1 | +$9.65M | |
| 2 | +$9.2M | |
| 3 | +$7.4M | |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$5.47M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$2.7M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$2.36M | |
| 3 | -$1.64M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.41M |
| 5 |
SG Americas Securities
New York
|
-$1.04M |